We only have limited information for this firm. Consider the following firms which have provided more information:
DLA Piper offers particular strength in M&A and corporate work in the PRC life sciences market, with experience in providing assistance both for financial services investors and for research companies operating in China. The team is led jointly by regulatory and IP specialist Ting Xiao, located at the Shanghai office, and the Hong Kong-based Sammy Fang. Private equity investment and corporate finance specialist Qiang Li, also based in Shanghai, is also key, as is the Hong Kong-based Christine Liu, who focuses on internal compliance and conduct investigations.
Legal 500 Editorial commentary
Key clients
- Aesthetic Medical International Holding Group Limited
- Arlington Capital Partners
Abbreviated data is displayed for this firm.
Work highlights
- Represented Blue Ocean Structure Investment Company Ltd., as majority shareholder of the New York-listed Global Cord Blood Corporation, in its attempt through proxy contest to control the board of directors of Global Cord.
- Advised Arlington Capital Partners and Everest Clinical Research on its acquisition of U.S. based Brightech International.
Abbreviated data is displayed for this firm.